Phyllis Gotlib Sells 3,707 Shares of American Well (NYSE:AMWL) Stock

American Well Corporation (NYSE:AMWL) insider Phyllis Gotlib sold 3,707 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $4.85, for a total transaction of $17,978.95. Following the sale, the insider owned 119,870 shares of the company’s stock, valued at $581,369.50. This trade represents a 3.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Phyllis Gotlib also recently made the following trade(s):

• On Monday, December 1st, Phyllis Gotlib sold 3,574 shares of American Well stock. The stock was sold at an average price of $4.06, for a total transaction of $14,510.44.

American Well Stock Performance

Shares of AMWL stock traded up $0.36 during mid-day trading on Monday, reaching $5.21. 218,794 shares of the company’s stock traded hands, compared to its average volume of 179,991. The firm has a market capitalization of $85.35 million, a PE ratio of -0.72 and a beta of 1.26. American Well Corporation has a 12 month low of $3.71 and a 12 month high of $12.95. The firm has a 50 day moving average price of $4.43 and a two-hundred day moving average price of $6.15.

American Well (NYSE:AMWL) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($1.74) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.83) by $0.09. The company had revenue of $56.29 million for the quarter, compared to the consensus estimate of $54.56 million. American Well had a negative net margin of 42.80% and a negative return on equity of 39.80%. As a group, equities analysts expect that American Well Corporation will post -9.34 earnings per share for the current fiscal year.

Institutional Trading of American Well

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Headlands Technologies LLC bought a new stake in American Well in the second quarter worth $39,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of American Well in the third quarter valued at $62,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of American Well in the 2nd quarter worth about $89,000. Engineers Gate Manager LP purchased a new position in shares of American Well during the 2nd quarter worth about $101,000. Finally, Prelude Capital Management LLC bought a new position in American Well during the 3rd quarter valued at about $86,000. Hedge funds and other institutional investors own 56.05% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on AMWL. Stifel Nicolaus cut their price target on American Well from $8.00 to $6.00 and set a “hold” rating for the company in a report on Wednesday, November 5th. Morgan Stanley lowered their target price on American Well from $10.50 to $6.00 and set an “equal weight” rating for the company in a research report on Thursday, December 18th. Wells Fargo & Company cut their target price on shares of American Well from $12.00 to $9.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Wall Street Zen downgraded shares of American Well from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of American Well in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, American Well has an average rating of “Hold” and an average price target of $7.58.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.